Methyl salicylate
Gingivitis
University of TaubateSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Gingivitis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
1,8-CINEOL University of Taubate | Phase 4 | BB |
APIGUARD University of Taubate | Phase 4 | BB |
Zinc chloride University of Taubate | Phase 4 | BB |
Menthol University of Taubate | Phase 4 | BB |
CYPROTERONE Postgraduate Institute of Dental Sciences Rohtak | D |
View all 9 →
Same molecule, other indications
Methyl salicylate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →